EDGAR Filing Documents for 0001628280-22-014544

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001628280-22-014544

Filing Date

2022-05-16

Accepted

2022-05-16 17:17:23

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	zentalis-followxonprosuppa.htm	424B5	406882
2	EX-FILING FEES	exhibit107-followxonprosupp.htm	EX-FILING FEES	26398
3		logo.jpg	GRAPHIC	38416
	Complete submission text file	0001628280-22-014544.txt		485612

Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018

Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791

Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255769 | Film No.: 22930955
SIC: 2834 Pharmaceutical Preparations